Get started
Author

Yujie Ding

Clinical Efficacy of ONC201 in H3K27M-Mutant Diffuse Midline Gliomas Is Driven by Disruption of Integrated Metabolic and Epigenetic Pathways
2023 · Sriram Venneti, Abed Rahman Kawakibi, et al. · Cancer Discovery · 162
PDF
Antimicrobial peptide functionalized gold nanorods combining near-infrared photothermal therapy for effective wound healing
2022 · Xinyu Xu, Yujie Ding, et al. · Colloids and Surfaces B Biointerfaces · 44
Anticancer effect of rationally designed α-helical amphiphilic peptides
2022 · Fang Pan, Yueping Li, et al. · Colloids and Surfaces B Biointerfaces · 32
Highly selective performance of rationally designed antimicrobial peptides based on ponericin-W1
2022 · Songwei Lv, Jingfang Wang, et al. · Biomaterials Science · 28
Table S10 from Clinical Efficacy of ONC201 in H3K27M-Mutant Diffuse Midline Gliomas Is Driven by Disruption of Integrated Metabolic and Epigenetic Pathways
2023 · Sriram Venneti, Abed Rahman Kawakibi, et al. · 2
Table S13 from Clinical Efficacy of ONC201 in H3K27M-Mutant Diffuse Midline Gliomas Is Driven by Disruption of Integrated Metabolic and Epigenetic Pathways
2023 · Sriram Venneti, Abed Rahman Kawakibi, et al. · 1
Genome assembly and annotation of Polygonatum cyrtonema Hua
2026 · Zhigang Han, Yan Shi, et al. · Figshare
A haplotype-resolved genome reveals intron expansion and enzyme innovation associated with the starch-to-fructan shift in Polygonatum cyrtonema
2026 · Zhigang Han, Yan Shi, et al. · Plant Communications
Loss of Arginase 2 Promotes Lung Metastasis in immune-competent hosts via Nitric Oxide Synthase 2-Dependent Th17 Response
2026 · Shu-Ting Chou, Xiaoyong Wang, et al. · bioRxiv (Cold Spring Harbor Laboratory)
Dual-modified starch with controlled gelatinization and OSA esterification modulates freeze-thaw stability of emulsified myofibrillar protein gels: Insights into phase evolution
2026 · Yanshun Xu, Yuxin Ding, et al. · SSRN Electronic Journal
Loss of Arginase 2 Promotes Lung Metastasis in Immunocompetent Hosts via Nitric Oxide Synthase 2-Dependent Th17 Response
2026 · Shu-Ting Chou, Xiaoyong Wang, et al. · SSRN Electronic Journal
Table S11 from Clinical Efficacy of ONC201 in H3K27M-Mutant Diffuse Midline Gliomas Is Driven by Disruption of Integrated Metabolic and Epigenetic Pathways
2025 · Sriram Venneti, Abed Rahman Kawakibi, et al.
Table S3 from Clinical Efficacy of ONC201 in H3K27M-Mutant Diffuse Midline Gliomas Is Driven by Disruption of Integrated Metabolic and Epigenetic Pathways
2025 · Sriram Venneti, Abed Rahman Kawakibi, et al.
Table S8 from Clinical Efficacy of ONC201 in H3K27M-Mutant Diffuse Midline Gliomas Is Driven by Disruption of Integrated Metabolic and Epigenetic Pathways
2025 · Sriram Venneti, Abed Rahman Kawakibi, et al.
Table S13 from Clinical Efficacy of ONC201 in H3K27M-Mutant Diffuse Midline Gliomas Is Driven by Disruption of Integrated Metabolic and Epigenetic Pathways
2025 · Sriram Venneti, Abed Rahman Kawakibi, et al.
Table S10 from Clinical Efficacy of ONC201 in H3K27M-Mutant Diffuse Midline Gliomas Is Driven by Disruption of Integrated Metabolic and Epigenetic Pathways
2025 · Sriram Venneti, Abed Rahman Kawakibi, et al.
Table S15 from Clinical Efficacy of ONC201 in H3K27M-Mutant Diffuse Midline Gliomas Is Driven by Disruption of Integrated Metabolic and Epigenetic Pathways
2025 · Sriram Venneti, Abed Rahman Kawakibi, et al.
Supplementary Data S1 from Clinical Efficacy of ONC201 in H3K27M-Mutant Diffuse Midline Gliomas Is Driven by Disruption of Integrated Metabolic and Epigenetic Pathways
2025 · Sriram Venneti, Abed Rahman Kawakibi, et al.
PDF
Table S16 from Clinical Efficacy of ONC201 in H3K27M-Mutant Diffuse Midline Gliomas Is Driven by Disruption of Integrated Metabolic and Epigenetic Pathways
2025 · Sriram Venneti, Abed Rahman Kawakibi, et al.
Table S9 from Clinical Efficacy of ONC201 in H3K27M-Mutant Diffuse Midline Gliomas Is Driven by Disruption of Integrated Metabolic and Epigenetic Pathways
2025 · Sriram Venneti, Abed Rahman Kawakibi, et al.
Table S6 from Clinical Efficacy of ONC201 in H3K27M-Mutant Diffuse Midline Gliomas Is Driven by Disruption of Integrated Metabolic and Epigenetic Pathways
2025 · Sriram Venneti, Abed Rahman Kawakibi, et al.
Supplementary Data S2 from Clinical Efficacy of ONC201 in H3K27M-Mutant Diffuse Midline Gliomas Is Driven by Disruption of Integrated Metabolic and Epigenetic Pathways
2025 · Sriram Venneti, Abed Rahman Kawakibi, et al.
Table S4 from Clinical Efficacy of ONC201 in H3K27M-Mutant Diffuse Midline Gliomas Is Driven by Disruption of Integrated Metabolic and Epigenetic Pathways
2025 · Sriram Venneti, Abed Rahman Kawakibi, et al.
Table S5 from Clinical Efficacy of ONC201 in H3K27M-Mutant Diffuse Midline Gliomas Is Driven by Disruption of Integrated Metabolic and Epigenetic Pathways
2025 · Sriram Venneti, Abed Rahman Kawakibi, et al.
Table S7 from Clinical Efficacy of ONC201 in H3K27M-Mutant Diffuse Midline Gliomas Is Driven by Disruption of Integrated Metabolic and Epigenetic Pathways
2025 · Sriram Venneti, Abed Rahman Kawakibi, et al.
Works count: 108
Citation count: 268
H-index: 4
I10-index: 4
Year
Topic
Type